NCT02013492
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Diseases, +42 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Stage IV Melanoma
Explore clinical trials studying Stage IV Melanoma. Study availability and eligibility vary by location and protocol.
69 public trials
0 recruiting studies
Stage IV Melanoma trial results
NCT01127451
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
- Locations
-
- Encinitas, California, United States
- Los Angeles, California, United States
- Washington D.C., District of Columbia, United States
- Chicago, Illinois, United States
NCT02296112
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +13 more
- Locations
-
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
NCT01037790
- Conditions
- Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Adult Central Nervous System Germ Cell Tumor, +74 more
- Locations
-
- Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States
- Conditions
- BRAF Mutant Melanoma, Melanoma, Neoplasms, +13 more
- Locations
-
- Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, North Carolina, United States
NCT01328535
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00498979
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +25 more
- Locations
-
- Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT01103635
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
- Locations
-
- Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic
NCT02094872
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
- Locations
-
- Mayo Clinic Cancer Center Scottsdale, Arizona, United States
- Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States
- Mayo Clinic Cancer Center Jacksonville, Florida, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
NCT02676869
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
- Locations
-
- Royal Brisbane Womens Hospital Brisbane, Queensland, Australia
- Princess Alexandra Hospital Brisbane, Queensland, Australia
- Greenslopes Private Hospital Brisbane, Queensland, Australia
- Flinders Medical Centre Adelaide, South Australia, Australia